Sudair Pharma continued its mission to support national health priorities through its active participation in the Saudi Heart Association Conference held in October 2025. The company showcased its Saventi platform and its innovative cardiovascular portfolio through a dedicated booth designed to engage healthcare professionals, specialists, and the community.
During the event, Sudair Pharma signed a Memorandum of Understanding with the Saudi Heart Association, establishing a strategic collaboration aimed at strengthening joint awareness initiatives, improving patient education, and supporting national programs focused on prevention and treatment of cardiovascular diseases.
Throughout the conference, Sudair Pharma’s team connected with visitors, shared scientific material on heart health, and presented the company’s latest pharmaceutical advancements that contribute to building a healthier future. This engagement reflects the company’s ongoing commitment to supporting national health goals and reinforcing awareness of heart disease as one of the most important public health challenges.
The company’s participation aligns with Sudair Pharma’s broader vision to promote community health, empower national capabilities, and contribute to a more sustainable healthcare ecosystem in Saudi Arabia.
